Home/Ventyx Biosciences/John G. O'Gorman
JG

John G. O'Gorman

Former Chief Financial Officer

Ventyx Biosciences

Ventyx Biosciences Pipeline

DrugIndicationPhase
VTX002Ulcerative ColitisPhase 2
VTX2735Systemic Inflammatory DiseasesPhase 1
VTX3232CNS / Neuroinflammatory DiseasesPreclinical/Phase 1